On the other hand, the literature reports that curcumin has dose-dependent activity in treating the A549 human lung cancer cell line; doses of 20 and 40 μM lead to the downregulation of Nuclear Factor-kappa B (NF-kB) [32]. Here, NFKB1 is linked to lung carcinoma.